EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autophagy modulators in type 2 diabetes: A new perspective

Ayah Talal Zaidalkilani, Hayder M Al-Kuraishy, Esraa H Fahad, Ali I Al-Gareeb, Yaser Hosny Ali Elewa iD, Mahmoud Hosny Zahran iD, Athanasios Alexiou iD, Marios Papadakis, Ammar Al-Farga, Gaber El-Saber Batiha iD

Journal of Diabetes · 2024

DOI: 10.1111/1753-0407.70010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes, 2024. Verfasst von Ayah Talal Zaidalkilani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Autophagy, Insulin-Secreting Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projekt DEAL, University of Witten-Herdecke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) is a chronic metabolic disorder caused by defective insulin signaling, insulin resistance, and impairment of insulin secretion. Autophagy is a conserved lysosomal‐dependent catabolic cellular pathway involved in the pathogenesis of T2D and its complications. Basal autophagy regulates pancreatic β‐cell function by enhancing insulin release and peripheral insulin sensitivity. Therefore, defective autophagy is associated with impairment of pancreatic β‐cell function and the development of insulin rersistance (IR). However, over‐activated autophagy increases apoptosis of pancreatic β‐cells leading to pancreatic β‐cell dysfunction. Hence, autophagy plays a double‐edged sword role in T2D. Therefore, the use of autophagy modulators including inhibitors and activators may affect the pathogenesis of T2D. Hence, this review aims to clarify the potential role of autophagy inhibitors and activators in T2D. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2AutophagyInsulin-Secreting CellsHumansInsulin ResistanceAnimalsSignal TransductionInsulinApoptosis

Stichwörter der Autor:innen

autophagyinsulin resistancetype 2 diabetes mellitusβ‐cells

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Nutrition, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan.
  • Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
  • Department of Histology and Cytology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
  • Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
  • Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

ORCID-Profile: Yaser Hosny Ali Elewa, Mahmoud Hosny Zahran, Athanasios Alexiou, Gaber El-Saber Batiha

Förderung

  • Projekt DEAL
  • University of Witten-Herdecke

Zitieren

APA

Zaidalkilani, A. T., Al-Kuraishy, H. M., Fahad, E. H., Al-Gareeb, A. I., Elewa, Y. H. A., Zahran, M. H., Alexiou, A., Papadakis, M., Al-Farga, A., & Batiha, G. E. (2024). Autophagy modulators in type 2 diabetes: A new perspective. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70010

Vancouver

Zaidalkilani AT, Al-Kuraishy HM, Fahad EH, Al-Gareeb AI, Elewa YHA, Zahran MH, et al. Autophagy modulators in type 2 diabetes: A new perspective. Journal of Diabetes. 2024. doi:10.1111/1753-0407.70010

BibTeX
@article{Zaidalkilani2024,
  author = {Zaidalkilani, Ayah Talal and Al-Kuraishy, Hayder M and Fahad, Esraa H and Al-Gareeb, Ali I and Elewa, Yaser Hosny Ali and Zahran, Mahmoud Hosny and Alexiou, Athanasios and Papadakis, Marios and Al-Farga, Ammar and Batiha, Gaber El-Saber},
  title = {Autophagy modulators in type 2 diabetes: A new perspective},
  journal = {Journal of Diabetes},
  year = {2024},
  doi = {10.1111/1753-0407.70010}
}
Kostenlos starten →